Advance Nano hires biopharma head

Aug. 3, 2005 — Advance Nanotech Inc. (OTC.BB: AVNA), a provider of financing and support services for nanotechnology commercialization, announced the appointment of Michael Helmus as senior vice president, biopharma.

The company said Helmus will be responsible for managing all of the firm’s partnerships and investments related to the biopharma and life sciences fields. He will report directly to Advance Nanotech CEO Magnus Gittins.

Helmus was previously vice president of advanced biomaterials at Boston Scientific. Prior to that, he held research and development positions with organizations including Edwards Lifesciences, Baxter CVS, Pfizer, and Arthur D. Little.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.